These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 15813919)
1. Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell graft. Dinser R; Grgic A; Kim YJ; Pfreundschuh M; Schubert J Eur J Haematol; 2005 May; 74(5):438-41. PubMed ID: 15813919 [TBL] [Abstract][Full Text] [Related]
2. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172 [TBL] [Abstract][Full Text] [Related]
4. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Singh N; Limaye AP; Forrest G; Safdar N; Muñoz P; Pursell K; Houston S; Rosso F; Montoya JG; Patton P; Del Busto R; Aguado JM; Fisher RA; Klintmalm GB; Miller R; Wagener MM; Lewis RE; Kontoyiannis DP; Husain S Transplantation; 2006 Feb; 81(3):320-6. PubMed ID: 16477215 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease. Verma A; Williams S; Trifilio S; Zembower T; Mehta J Bone Marrow Transplant; 2004 May; 33(10):1065-6. PubMed ID: 15048146 [No Abstract] [Full Text] [Related]
6. Combination antifungal therapy for invasive aspergillosis. Marr KA; Boeckh M; Carter RA; Kim HW; Corey L Clin Infect Dis; 2004 Sep; 39(6):797-802. PubMed ID: 15472810 [TBL] [Abstract][Full Text] [Related]
7. Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin. Howell A; Midturi J; Sierra-Hoffman M; Carpenter J; Hurley D; Winn R Med Mycol; 2005 Nov; 43(7):651-5. PubMed ID: 16396251 [TBL] [Abstract][Full Text] [Related]
8. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole. Forestier E; Remy V; Lesens O; Martinot M; Hansman Y; Eisenmann B; Christmann D Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):347-9. PubMed ID: 15889298 [TBL] [Abstract][Full Text] [Related]
9. Voriconazole in the treatment of invasive aspergillosis in kidney transplant recipients. Veroux M; Corona D; Gagliano M; Sorbello M; Macarone M; Cutuli M; Giuffrida G; Morello G; Paratore A; Veroux P Transplant Proc; 2007; 39(6):1838-40. PubMed ID: 17692627 [TBL] [Abstract][Full Text] [Related]
11. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation. Gahn B; Schub N; Repp R; Gramatzki M Eur J Med Res; 2007 Aug; 12(8):337-40. PubMed ID: 17933709 [TBL] [Abstract][Full Text] [Related]
12. Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient. Damaj G; Ivanov V; Le Brigand B; D'incan E; Doglio MF; Bilger K; Faucher C; Vey N; Gastaut JA Ann Hematol; 2004 Jun; 83(6):390-3. PubMed ID: 14666380 [TBL] [Abstract][Full Text] [Related]
13. Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin. Madureira A; Bergeron A; Lacroix C; Robin M; Rocha V; de Latour RP; Ferry C; Devergie A; Lapalu J; Gluckmana E; Socié G; Ghannoum M; Ribaud P Int J Antimicrob Agents; 2007 Dec; 30(6):551-4. PubMed ID: 18029149 [TBL] [Abstract][Full Text] [Related]
14. Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole. Tsiodras S; Zafiropoulou R; Giotakis J; Imbrios G; Antoniades A; Manesis EK Transpl Infect Dis; 2004 Mar; 6(1):37-40. PubMed ID: 15225226 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. MacCallum DM; Whyte JA; Odds FC Antimicrob Agents Chemother; 2005 Sep; 49(9):3697-701. PubMed ID: 16127042 [TBL] [Abstract][Full Text] [Related]
16. [Efficacies and clinical roles of new antifungal agents]. Tokimatsu I; Kadota J Nihon Ishinkin Gakkai Zasshi; 2006; 47(3):155-9. PubMed ID: 16940948 [TBL] [Abstract][Full Text] [Related]
17. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient. Sims-McCallum RP Am J Health Syst Pharm; 2003 Nov; 60(22):2352-6. PubMed ID: 14652986 [No Abstract] [Full Text] [Related]